Dilated cardiomyopathy: so many cardiomyopathies!

Eur Heart J

Cardiovascular Department, Center for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Integrata (ASUITS), University of Trieste, Via P. Valdoni 7, 34100 Trieste, Italy.

Published: October 2020

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehz908DOI Listing

Publication Analysis

Top Keywords

dilated cardiomyopathy
4
cardiomyopathy cardiomyopathies!
4
dilated
1
cardiomyopathies!
1

Similar Publications

Dilated cardiomyopathy (DCM) is the ultimate manifestation of the myocardial response to various genetic and environmental changes and is characterized mainly by impaired left ventricular systolic and diastolic function. DCM can ultimately lead to heart failure, ventricular arrhythmia (VA), and sudden cardiac death (SCD), making it a primary indication for heart transplantation. With advancements in modern medicine, several novel techniques for evaluating myocardial involvement and disease severity from diverse perspectives have been developed.

View Article and Find Full Text PDF

Enhancing cardiovascular disease classification in ECG spectrograms by using multi-branch CNN.

Comput Biol Med

January 2025

Department of Electrical and Electronics Engineering, Sri Sivasubramaniya Nadar College of Engineering, Chennai, India. Electronic address:

Cardiovascular disease (CVD) is caused by the abnormal functioning of the heart which results in a high mortality rate across the globe. The accurate and early prediction of various CVDs from the electrocardiogram (ECG) is vital for the prevention of deaths caused by CVD. Artificial intelligence (AI) is used to categorize and accurately predict various CVDs.

View Article and Find Full Text PDF

Background: Myocardial disease is an important component of the wide field of cardiovascular disease. However, the phenomenon of multiple myocardial diseases in a single patient remains understudied.

Aim: To investigate the prevalence and impact of myocarditis in patients with genetic cardiomyopathies and to evaluate the outcomes of myocarditis treatment in the context of cardiomyopathies.

View Article and Find Full Text PDF

Immuno-fibrotic networks and their protein mediators, such as cytokines and chemokines, have increasingly been appreciated for their critical role in cardiac healing and fibrosis during cardiomyopathy. Immune activation, trafficking, and extravasation are tightly regulated to ensure a targeted and effective response against non-self antigens/pathogens while preserving tolerance towards self-antigens and coordinate fibrotic responses for efficient scar formation, a distinction that is severely compromised during chronic diseases. It is clear that immune cells are not only the critical regulators of post-infarct healing and scarring but are also the key players in regulating fibroblast activation during left-ventricular (LV) remodeling.

View Article and Find Full Text PDF

Cardiomyopathy represents the most important life-limiting condition of Duchenne muscular dystrophy (DMD) patients after the age of 20. Genetic alterations in the DMD gene result in the absence of functional dystrophin protein, leading to skeletal/cardiac muscle impairment. The DMD incidence is one in 5000 live male births.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!